openPR Logo
Press release

North America Bioanalytical Testing Services Market could be worth 1,798.03 million by 2030,,says Business Market Insights

01-28-2025 11:54 AM CET | Health & Medicine

Press release from: Business Market Insights

The North America bioanalytical testing services market was valued at US$ 1,798.03 million in 2022 and is expected to reach US$ 3,971.42 million by 2030; it is estimated to grow at a CAGR of 10.4% from 2022 to 2030.

Get PDF Sample Report + All Related Table and Graphs @: https://www.premiummarketinsights.com/sample/BMIRE00029563?utm_source=OpenPR&utm_medium=10823

Competitive Landscape: North America Bioanalytical Testing Services Market:

Bioanalytical testing services are used for the quantitative estimation of drugs and their metabolites in biological fluids. This testing is performed in the early stages of the drug development. Various biotechnology companies are engaging in collaborations to accelerate R&D activities and scale them up on a global level. Several ongoing drug research studies have shown positive outcomes for effectively treating chronic disorders such as cancer, neurological disorders, and autoimmune disorders. An upsurge in the prevalence of such disorders, coupled with the increase in R&D activities, would create demand for bioanalytical testing services in the coming years. An increase in the incidence of rare disorders such as amyloidosis, adrenoleukodystrophy, and Ehlers-Danlos syndrome has further bolstered the R&D activities for the development of interventions against them, which has been generating the demand for specific bioanalytical testing services. According to the Food and Drug Administration (FDA), in 2022, the Center for Drug Evaluation and Research (CDER) approved 37 novel drugs. Out of 37, 20 drugs were approved for rare diseases. Similarly, Congressional Budget Office (CBO) reported that the FDA approved 38 new drugs per year, on average, from 2010 through 2019 (with a peak of 59 in 2018), which is 60% more than the yearly average over the previous decade. Thus, the continuous efforts of drug companies to discover and develop drugs against rare and emerging diseases are expected to provide lucrative opportunities for the expansion of the bioanalytical testing service businesses during the forecast period.

SGS SA
Pharmaron Beijing Co Ltd
Element Materials Technology Group Ltd
CD BioSciences Inc
Charles River Laboratories International Inc
Eurofins Scientific SE
Labcorp Drug Development Inc
Syneos Health Inc
KCAS Bioanalytical Biomarker Services LLC
ICON Plc,
Intertek Group Plc
Bottom of Form

Chapter Details of North America Bioanalytical Testing Services Market:
Part 01: Executive Summary
Part 02: Scope of The Report
Part 03: North America Bioanalytical Testing Services Market Landscape
Part 04: North America Bioanalytical Testing Services Market Sizing
Part 05: North America Bioanalytical Testing Services Market Segmentation by Product
Part 06: Five Forces Analysis
Part 07: Customer Landscape
Part 08: Geographic Landscape
Part 09: Decision Framework
Part 10: Drivers and Challenges
Part 11: Market Trends
Part 12: Vendor Landscape
Part 13: Vendor Analysis

Interested in Purchasing this Report? Click here @ https://www.premiummarketinsights.com/buy/BMIRE00029563?utm_source=OpenPR&utm_medium=10823

Contact Us:
If you have any queries about this report or if you would like further information, please contact us:
Contact Person: Sonam Patil
SE-mail: sales@permiummarketinsights.com
Phone: +1-646-491-9876

About Us:
Bussiness Market Insights is a one stop shop of market research reports and solutions to various companies across the globe. We help our clients in their decision support system by helping them choose most relevant and cost effective research reports and solutions from various publishers.
The market research industry has changed in last decade. As corporate focus has shifted to niche markets and emerging countries, a number of publishers have stepped in to fulfil these information needs. We have experienced and trained staff that helps you navigate different options and lets you choose best research solution at most effective cost.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release North America Bioanalytical Testing Services Market could be worth 1,798.03 million by 2030,,says Business Market Insights here

News-ID: 3837075 • Views:

More Releases from Business Market Insights

North America Demineralized Whey Powder Market Research Report
The North America demineralized whey powder market was valued at US$ 172.56 million in 2023 and is expected to reach US$ 241.68 million by 2031; it is estimated to record a CAGR of 4.3% from 2023 to 2031. The report includes an executive summary, regional economic outlook, and summary sections which provide a consistent analysis of the North America Demineralized Whey Powder Market 2031. in addition, the report within the market
North America Defibrillator Market Overview by Top Manufacturers 2028
The defibrillator market in North America is expected to grow from US$ 4,575.28 million in 2021 to US$ 6,597.93 million by 2028; it is estimated to grow at a CAGR of 5.4% from 2021 to 2028. The report includes an executive summary, regional economic outlook, and summary sections which provide a consistent analysis of the North America Defibrillator Market 2028. in addition, the report within the market overview section outlines PLC
North America Defense Integrated Antenna Market Recent Trends by Forecast to 202 …
North America defense integrated antenna market is expected to grow from US$ 461.89 million in 2022 to US$ 707.29 million by 2028; it is estimated to grow at a CAGR of 7.4% from 2022 to 2028. The report includes an executive summary, regional economic outlook, and summary sections which provide a consistent analysis of the North America Defense Integrated Antenna Market 2028. in addition, the report within the market overview section
Cancer Chemotherapy Market Analysis, Share, Trend, Industry Report Forecast till 2031
Cancer Chemotherapy Market Analysis, Share, Trend, Industry Report Forecast till …
The cancer chemotherapy market size is expected to reach US$ 84,044.04 million by 2031 from US$ 39,509.70 million in 2024. The market is estimated to record a CAGR of 11.5% from 2025 to 2031. Europe Commercial Refrigeration Market Overview Executive Summary and Global Market Analysis: The global cancer chemotherapy market is experiencing significant growth driven by rising global incidence of cancer coupled with an aging population, increasing access to oncology care in

All 5 Releases


More Releases for Bioanalytical

Government-Led Initiatives Propel Bioanalytical Testing Services Market Amidst P …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the Bioanalytical Testing Services Market Through 2025? In recent years, there has been significant growth in the size of the bioanalytical testing services market. It is projected to expand from $3.45 billion in 2024 to $3.71 billion in 2025, demonstrating a compound annual
Government-Led Initiatives Propel Bioanalytical Testing Services Market Amidst P …
The Bioanalytical Testing Services Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Bioanalytical Testing Services Market Size and Projected Growth Rate? In recent times, the bioanalytical testing services market has seen substantial growth. The market size is projected to increase from $3.45 billion
Key Influencer in the Large Molecule Bioanalytical Technologies Market 2025: Rol …
What Is the Forecasted Market Size and Growth Rate for the Large Molecule Bioanalytical Technologies Market?_x000D_ The market size for large molecule bioanalytical technologies has seen significant expansion in the past few years. The market is forecasted to swell from $10.19 billion in 2024 to $11.7 billion in 2025, representing a compound annual growth rate (CAGR) of 14.9%. This historical surge stems from a rise in biotechnology research investment, expansion of
Bioanalytical Services Market Thriving on Medical Advancement: The Booming Bioan …
Bioanalytical Services Market to Record an Exponential CAGR by 2031 - Exclusive Report by InsightAce Analytic Pvt. Ltd. InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Bioanalytical Services Market- (By Type (Pre-Clinical Studies, Clinical Studies), By End-User (Pharmaceutical companies, Biotechnology companies, CROs, CDMOs)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031." According to the latest research by InsightAce Analytic, the Global Bioanalytical Services Market
Bioanalytical Testing Services Market Size Forecast Between 2023-2032
The bioanalytical testing services market is on a robust growth trajectory, with its size recorded at USD 4.2 billion in 2022. Projections indicate a significant expansion to USD 11.4 billion by 2032, reflecting a Compound Annual Growth Rate (CAGR) of 10.7% from 2023 to 2032. This article delves into the competitive landscape, growth prospects, opportunities, drivers, constraints, key market players, current trends, and regional insights shaping this dynamic market. Download Free
Cell & Gene Therapy Bioanalytical Testing Services Market Thriving Globally | Bi …
Cell & gene therapy bioanalytical testing services involve comprehensive analysis and evaluation of cellular and genetic therapies to ensure safety, efficacy, and quality. These services encompass a range of analytical techniques to assess factors like potency, purity, identity, and stability of therapeutic products. They play a crucial role in the development and regulatory approval of cell and gene therapies by providing accurate and reliable data to support decision-making processes. Bioanalytical